Metropolitan Life Insurance Company (MetLife)’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,354	Closed	-$6.71K	–	2436
2023 Q2	$6.71K	Buy	+3,354	New	+$6.71K	﹤0.01%	2436